Brinda Balakrishnan
Director/Board Member at AURINIA PHARMACEUTICALS INC.
Net worth: 134 148 $ as of 30/03/2024
Profile
Brinda Balakrishnan had a career history that included founding Vision Medicines, Inc. in 2013, where she held the title of VP-Corporate Strategy & Product Development from 2013 to 2016.
Currently, she is an Independent Director at Aurinia Pharmaceuticals, Inc. since 2021 and the Chief Business Development Officer & SVP at BioMarin Pharmaceutical, Inc. since 2016.
Dr. Balakrishnan has an educational background that includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/05/2023 | 26,776 ( 0.02% ) | 134 148 $ | 30/03/2024 |
Brinda Balakrishnan active positions
| Companies | Position | Start |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 31/12/2015 |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | 13/06/2021 |
Former positions of Brinda Balakrishnan
| Companies | Position | End |
|---|---|---|
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Founder | 31/12/2015 |
Training of Brinda Balakrishnan
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Brinda Balakrishnan
